Emergency Tuberculosis Project (WB-P160947)

Countries
  • Papua New Guinea
Where the impacts of the investment may be experienced.
Financial Institutions
  • World Bank (WB)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Approved
Bank Risk Rating
B
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
May 31, 2017
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
Borrower
National Parliament of Papua New Guinea, National Department of Health
The holder of the loan, grant, or other investment.
Sectors
  • Education and Health
The service or industry focus of the investment. A project can have several sectors.
Investment Amount (USD)
$ 15.00 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Project Cost (USD)
$ 15.00 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please see updated project documentation for more information.
Primary Source

Original disclosure @ WB website

Updated in EWS Oct 24, 2017

Disclosed by Bank Oct 13, 2016


Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
According to World Bank website, the Emergency Tubercolosis Project aims to improve the quality and expand the coverage and utilization of health services to control the spread of tuberculosis in targeted areas of Papua New Guinea by strengthening programmatic management of tuberculosis. There are three components to the project, as follows: Component 1. Early detection of active tuberculosis patients. The IDA credit will finance the implementation of ACF strategies, which have been developed for Western Province and are also included in the NCD TB plan. Financing will be provided for procurement of diagnostic medical devices and consumables, technical assistance, and other eligible expenditures deemed necessary for the early detection of active TB patients. Component 2. Effective treatment of drug-susceptible and drug-resistant tuberculosis patients. The project will support the effective treatment of both DS and DR TB patients, including the new short regimen for DR TB patients, through three subcomponents: improving clinical management of DS TB and DR TB; strengthening the directly observed treatment implementation and reduce the loss of follow up of patients in the BMUs; and supporting social mobilization in targeted areas. Component 3. Strengthen the recipient’s systems for managing its health services delivery and tuberculosis response.
Investment Description
  • World Bank (WB)
Contact Information
Team Leader: Aneesa Arur No contact information provided at the time of disclosure. Implementing Agency: National Department of Health Paison Dakulala Dr. Email Address: paison_dakulala@health.gov.pg ACCOUNTABILITY MECHANISM OF WORLD BANK The World Bank Inspection Panel is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by a World Bank-financed project. If you submit a complaint to the Inspection Panel, they may investigate to assess whether the World Bank is following its own policies and procedures for preventing harm to people or the environment. You can contact the Inspection Panel or submit a complaint by emailing ipanel@worldbank.org. You can learn more about the Inspection Panel and how to file a complaint at: http://ewebapps.worldbank.org/apps/ip/Pages/Home.aspx.